Spotify, the world’s leading music streaming service, has always been known for its bold and innovative approach. In a groundbreaking move, Spotify has become the first streaming platform to embrace cannabis advertising through its new collaboration with Cresco Labs (CRLBF).

The campaign marks a significant convergence of two influential industries: cannabis and music streaming. Spotify boasts an impressive user base of over 220 million subscribers as of the first quarter of 2023, according to Statista, making it a prime target for advertisers seeking broad reach.

Cresco Labs, headquartered in Chicago, Illinois, is the owner of the renowned Sunnyside cannabis dispensary brand. The company believes that advertising on Spotify, one of the most frequented music streaming platforms, will effectively connect with cannabis enthusiasts—an unsurprising association given the historical link between music and marijuana.

Cory Rothschild, National Retail President of Cresco Labs, expressed the company’s enthusiasm for this groundbreaking partnership: “Audio streaming services represent a major opportunity for brands to reach large audiences in a targeted manner, and we’re excited to collaborate with Spotify to launch the first-ever cannabis ads from our Sunnyside national retail brand. Our Sunnyside advertising strategy is built on a data ecosystem enabling best-in-class targeting and measurement. Spotify’s platform will enable our marketing team to target our ads compliantly and profitably to our core shoppers in Illinois where we have a leading share in retail.”

Rothschild also highlighted the broader significance of this partnership, stating, “This important partnership is not only a step in normalizing cannabis, but it also showcases the sophistication and quality of marketing that we have unlocked at Cresco Labs.”

The Cresco ad campaign is expected to center on the Sunnyside “shopping experience.” It will feature 30-second audio advertisements and in-app digital banners, primarily focusing on the company’s proprietary e-commerce platform.

Spotify has earned a reputation for being an affordable platform for advertisers, with per-ad prices starting at just $250.

In this innovative partnership, Spotify and Cresco Labs are not only pushing boundaries but also contributing to the evolving landscape of cannabis advertising, marking a significant step toward its normalization.

 

Source: The Street

EXPLORE MORE NEWS

Major Corporations Investing in Cannabis

As cannabis legalization continues to spread across the country, major corporations are increasingly taking notice and investing in the industry. In April of 2023, a major beverage company announced a $100 million investment in a cannabis-infused drink startup, signaling the growing trend of large corporations entering the cannabis space.

Cannabis in the Wild: Exploring Natural Growth and its Impact on Markets in the United States

Cannabis, a versatile plant with a long history of human cultivation, has been making headlines in recent years. While it’s commonly associated with recreational use and medicinal properties, one intriguing aspect is its natural growth in certain regions of the United States. This article delves into the science behind the cannabis plant and why specific regions are more hospitable to its growth. It also explores the implications of natural cannabis growth on the current markets, encompassing economic opportunities, genetic diversity, regulatory challenges, and environmental impact.

Proposed Legislation Aims to Address Cannabis Taxation Issues in California

Under the Adult Use of Marijuana Act, the cannabis excise tax in California is currently set at 15% of gross receipts from licensed retail cannabis sales. In addition to this state-level tax, many local governments impose their own additional taxes on cannabis, with some jurisdictions, including Los Angeles, charging as high as 10%.

Revolutionary Shift: US Health Department Proposes Reclassifying Marijuana from Schedule I to Schedule III

In a groundbreaking move that has the potential to reshape the landscape of cannabis regulations, the U.S. Department of Health and Human Services (HHS) has taken a bold step by formally recommending the reclassification of marijuana from Schedule I to Schedule III under federal law. This historic decision signifies a seismic shift in perspective, indicating that the nation’s premier health agency no longer views cannabis as a substance with high abuse potential and zero medical value.

Newsletter